Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Nippon India Nifty Pharma ETF |
[Equity: Index] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.40 |
Equity |
99.97 |
Trep |
0.43 |
|
|
Concentration Analysis |
Top 5 Holdings |
59.03% |
Top 10 Holdings |
79.12% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
99.97 |
Cash |
0.03 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
4.55 |
PE Ratio |
31.97 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
21.98 |
Cipla Limited |
11.43 |
DIVI LABORATORIES LTD |
9.95 |
Dr Reddys Laboratories Limited |
9.81 |
Lupin Limited |
5.86 |
Torrent Pharmaceuticals Limited |
4.76 |
Laurus Labs Limited |
4.29 |
Glenmark Pharmaceuticals Limited |
3.70 |
Aurobindo Pharma Limited |
3.68 |
Alkem Laboratories Limited |
3.66 |
MANKIND PHARMA LIMITED |
3.57 |
Zydus Lifesciences Limited |
3.13 |
Biocon Limited |
2.68 |
IPCA Laboratories Limited |
2.46 |
Abbott India Limited |
2.09 |
Gland Pharma Limited |
1.90 |
J B Chemicals and Pharma Ltd |
1.78 |
Ajanta Pharma Limited |
1.34 |
Natco Pharma Limited |
0.99 |
Granules India Limited |
0.91 |
Tri Party Repo |
0.43 |
Net Current Assets |
-0.40 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|